RTKN2 knockdown alleviates the malignancy of breast cancer cells by regulating the Wnt/β-catenin pathway
Abstract RTKN2 is a new effector protein of Rho GTPase, and has been indicated to be a tumor inhibitor in colon cancer. In this article, we explored the function of RTKN2 in BC cell development. RTKN2 expression in BC tissues and BC cell lines was evaluated by RT-qPCR and Western blot assay. CCK-8,...
Main Authors: | Xiaomei Zhang, Jian Wang, Haiying Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-50153-w |
Similar Items
-
Knockdown of LINC00702 inhibits the growth and induces apoptosis of breast cancer through the Wnt/β-catenin pathway
by: Dahai Chai, et al.
Published: (2023-10-01) -
Knockdown of CD146 promotes endothelial-to-mesenchymal transition via Wnt/β-catenin pathway.
by: Zhao-Yu Zhang, et al.
Published: (2022-01-01) -
BMSCs alleviate liver cirrhosis by regulating Fstl1/Wnt/β-Catenin signaling pathway
by: Hanjing Zhangdi, et al.
Published: (2023-11-01) -
Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer
by: Jia Bian, et al.
Published: (2020-09-01) -
Docking studies reveal zerumbone targets β-catenin of the Wnt-β-catenin pathway in breast cancer
by: Fatima, Ayesha, et al.
Published: (2018)